Eton Pharmaceuticals (ETON) Asset Utilization Ratio (2020 - 2026)
Eton Pharmaceuticals (ETON) posted Asset Utilization Ratio of 0.81 for Q4 2025, up 19.23% sequentially from 0.68 in Q3 2025, and up 16.7% YoY from 0.7 in Q4 2024.
Eton Pharmaceuticals (ETON) Asset Utilization Ratio (2020 - 2026) Analysis & Trends
Eton Pharmaceuticals has reported Asset Utilization Ratio for 6 years, with the latest figure at 0.81 in Q4 2025.
- Quarterly Asset Utilization Ratio rose 16.7% year-over-year to 0.81 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.81 (up 16.7% YoY) and the FY2025 annual result came in at 0.95, up 31.4% from the prior year.
- Asset Utilization Ratio rose to 0.81 in Q4 2025 per ETON's latest filing, from 0.68 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 1.82 in Q1 2024 and troughed at 0.42 in Q1 2021.
- A 5-year average of 0.93 and a median of 0.81 in 2025 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2021 and 2025: Asset Utilization Ratio surged 5397.33% in 2021, then slumped 66.77% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.81 in 2021, then gained by 10.0% to 0.89 in 2022, then soared by 92.65% to 1.71 in 2023, then slumped by 59.28% to 0.7 in 2024, then gained by 16.7% to 0.81 in 2025.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.81, 0.68, and 0.63 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Eton Pharmaceuticals | 1.66 Bn | 1.63 Bn | 25.41 Mn | 0.96 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.96 |
| Dec 31, 2025 | 0.81 |
| Sep 30, 2025 | 0.68 |
| Jun 30, 2025 | 0.63 |
| Mar 31, 2025 | 0.60 |
| Dec 31, 2024 | 0.70 |
| Sep 30, 2024 | 1.69 |
| Jun 30, 2024 | 1.72 |
| Mar 31, 2024 | 1.82 |
| Dec 31, 2023 | 1.71 |
| Sep 30, 2023 | 1.05 |
| Jun 30, 2023 | 1.12 |
| Mar 31, 2023 | 0.97 |
| Dec 31, 2022 | 0.89 |
| Sep 30, 2022 | 0.82 |
| Jun 30, 2022 | 0.61 |
| Mar 31, 2022 | 0.48 |
| Dec 31, 2021 | 0.81 |
| Sep 30, 2021 | 0.56 |
| Jun 30, 2021 | 0.50 |